---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-000383"
form_type: "8-K"
ticker: "XLO"
cik: "0001840233"
company_name: "Xilio Therapeutics, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:26:35.795153+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Xilio receives Nasdaq deficiency notice for bid price below $1.00/share

## Summary
- Bid price closed below $1.00 for 30 consecutive business days; violates Minimum Bid Requirement.
- 180-day cure period expires July 17, 2024; must trade at $1.00+ for 10 consecutive days to regain compliance.
- May be eligible for extra 180-day period if transfer to Nasdaq Capital Market; no guarantee of success.
- Company will monitor bid price and evaluate options; potential delisting risk remains.

## SEC filing metadata
- accession: 0001558370-24-000383
- form_type: 8-K
- ticker: XLO
- cik: 0001840233
- company_name: Xilio Therapeutics, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840233/000155837024000383/0001558370-24-000383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840233/000155837024000383/xlo-20240119x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-000383
- JSON: https://secwatch.observer/filing/0001558370-24-000383.json
- Plain text: https://secwatch.observer/filing/0001558370-24-000383.txt

## Key facts
- Listing & Compliance Notices
  Xilio Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: January 19, 2024, Xilio Therapeutics, Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). ​ The Notice has no immediate effect on the listing of the Company’s com
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840233/000155837024000383/0001558370-24-000383-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.